In a press release published last week, the two companies announced they have entered an agreement for Jazz to acquire GW Pharma, the producer of the only FDA-approved CBD medication Epidiolex, for a total of $7.2 billion.
In this article Aaron Green sits down and interviews Mike McDonald, President and CEO at Ammonite, to learn more about their Dablicator™ oil applicator and Ammonite’s hardware platform strategy.
The post Hardware Platforms in Cannabis: A Q&A with Mike McDonald, President and CEO of Ammonite appeared first on Cannabis Industry Journal.
Complex Biotech Discovery Ventures (CBDV) has added an innovative testing solution to their repertoire of lab services: the vapor/smoke analyzer. In their lab embedded in the University of British Columbia, CBDV will now be able to offer clients the ability to test the very final stage of the plant’s lifecycle: the smoke that consumers inhale.
Cresco Labs will enter the Florida market with the acquisition of Bluma Wellness (and its subsidiary One Plant Florida) for an equity value of $213 million, expected to be finalized by the second quarter of this year.